Beskrivning
| Land | Finland |
|---|---|
| Sektor | Hälsovård |
| Industri | Bioteknik |
FIT Biotech Oy
Company release 3.1.2019 at 15:30 EET
Changes in FIT Biotech's Board of Directors
Juhani Pitkäkoski has resigned because of personal reasons from FIT Biotech Oy's ("Company", FITBIO: FN Finland) Board of Directors. Pitkäkoski has served as a member of FIT Biotech's Board of Directors since 2018.
Chitra Bharucha, Chairman of the Board of Directors, comments:
"I want to thank Juhani for the work he has done in the company's Board of Directors."
FIT Biotech Oy
Board of Directors
For further information:
Chitra Bharucha
Chairman of the Board of Directors
Tel: +44 7736 679347
Email: chitra@fitbiotech.com
Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000
FIT Biotech in brief
FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.
FIT Biotech applies its GTU® technology in its development projects, which at the time include gene-based treatments, genetic vaccines and research collaboration. Application areas include cancer (gene therapy) and infectious diseases such as HIV.
FIT Biotech K-shares are listed on the First North Finland market maintained by Nasdaq Helsinki Ltd.
DISTRIBUTION:
Nasdaq Helsinki
Principal media
www.fitbiotech.com
--
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: FIT Biotech Oy via Globenewswire